BIONET Corp.
1784.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.98B
Close$
Share Statistics
| Market cap | $2.98 Billion |
|---|---|
| Enterprise Value | $3.02 Billion |
| Dividend Yield | $0.88 (1.49%) |
| Earnings per Share | $1.02 |
| Beta | 0.47 |
| Outstanding Shares | 31,583,000 |
Return
| Return on Equity | 3.74% |
|---|---|
| Return on Assets | 1.49% |
| Return on Invested Capital | -0.55% |
Valuation & Multiples
| P/E Ratio | 52.48 |
|---|---|
| PEG | 71.33 |
| Price to Sales | 1.48 |
| Price to Book Ratio | 0.86 |
| Enterprise Value to Revenue | 2.34 |
| Enterprise Value to EBIT | -210.41 |
| Enterprise Value to Net Income | 65 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$0.31
Average shareholder expectationRevenue Estimate
$330.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$0.51
Average shareholder expectationRevenue Estimate
$355.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BIONET Corp.
80 employees
CEO: Qing Yuan Kang Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a global leader in umbilical cord blood preservation, serving clients across Taiwan and internationally. The company provides a comprehensive suite of stem cel...